Can nirmatrelvir/ritonavir treatment shorten the duration of COVID-19 isolation?

Can nirmatrelvir/ritonavir treatment shorten the duration of COVID-19 isolation?

BackgroundThe impact of nirmatrelvir/ritonavir treatment on shedding of viable virus in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is unclear.MethodsA prospective cohort study evaluating mildly ill COVID-19 patients was conducted. Virologic responses were compared between nirmatrel...

Full description

Bibliographic Details
Main Authors: Haein Kim, Jeong-Sun Yang, Jae-Hoon Ko, Myungsun Lee, Joo-Yeon Lee, Sehee Park, Jun-Won Kim, Younmin Shin, Jung-Min Lee, Yoo Jin Na, Byoung Kwon Park, Hyungjin Kim, Young Ho Lee, Jinyoung Yang, Kyungmin Huh, Sun Young Cho, Cheol-In Kang, Doo Ryeon Chung, Kyong Ran Peck
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Medicine
Subjects:
SARS-CoV-2
nirmatrelvir
culture
microbial viability
viral load
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.988559/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2022.988559/full

Similar Items